Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Work In Process (2018 - 2021)

Medifast's Work In Process history spans 4 years, with the latest figure at $3.4 million for Q3 2021.

  • For Q3 2021, Work In Process rose 22.96% year-over-year to $3.4 million; the TTM value through Sep 2021 reached $3.4 million, up 22.96%, while the annual FY2020 figure was $4.1 million, 0.92% down from the prior year.
  • Work In Process reached $3.4 million in Q3 2021 per MED's latest filing, up from $3.0 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $4.1 million in Q4 2019 to a low of $1.6 million in Q4 2018.
  • Average Work In Process over 4 years is $2.9 million, with a median of $2.9 million recorded in 2020.
  • Peak YoY movement for Work In Process: surged 162.89% in 2019, then dropped 23.13% in 2020.
  • A 4-year view of Work In Process shows it stood at $1.6 million in 2018, then soared by 162.89% to $4.1 million in 2019, then fell by 0.92% to $4.1 million in 2020, then dropped by 16.61% to $3.4 million in 2021.
  • Per Business Quant, the three most recent readings for MED's Work In Process are $3.4 million (Q3 2021), $3.0 million (Q2 2021), and $2.5 million (Q1 2021).